Reconstruction of human AML reveals stem cell origin and therapeutic targets for treatment resistant CD34(-/Lo) MLL-rearranged leukemia
Author(s)
Type
Conference Paper
Date Issued
2019-11-13
Date Acceptance
2019-11-01
Citation
Blood, 2019, 134, pp.1-3
ISSN
0006-4971
Publisher
American Society of Hematology
Start Page
1
End Page
3
Journal / Book Title
Blood
Volume
134
Copyright Statement
© 2019 by The American Society of Hematology
Sponsor
Wellcome Trust
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577160408027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
106954/Z/15/Z
Source
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
Subjects
Science & Technology
Life Sciences & Biomedicine
Hematology
Publication Status
Published
Start Date
2019-12-07
Finish Date
2019-12-10
Coverage Spatial
Orlando, FL
Date Publish Online
2019-11-13